Samy Babai

651 total citations
16 papers, 456 citations indexed

About

Samy Babai is a scholar working on Toxicology, Pharmacology and Genetics. According to data from OpenAlex, Samy Babai has authored 16 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Toxicology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Samy Babai's work include Pharmacovigilance and Adverse Drug Reactions (6 papers), Drug-Induced Adverse Reactions (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Samy Babai is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (6 papers), Drug-Induced Adverse Reactions (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Samy Babai collaborates with scholars based in France, Iran and New Zealand. Samy Babai's co-authors include Hervé Le-Louët, Dominique Hillaire‐Buys, Laurent Auclert, Pierrick Coupé, Sophie Gautier, Johana Béné, Marine Auffret, Guillaume Moulis, Joëlle Micallef and Jean‐Luc Faillie and has published in prestigious journals such as Scientific Reports, Medicine and British Journal of Dermatology.

In The Last Decade

Samy Babai

13 papers receiving 448 citations

Peers

Samy Babai
Saba Sile United States
Marius MacKenzie Netherlands
Stefano Di Giulio Italy
Seiichi Hayato Japan
Ziba Rahimi Iran
Kevin Rockich United States
Elisabeth del Río Spain
Tao Jin China
Beatriz Sánchez-Vega Spain
Kiichiro Jinde Japan
Saba Sile United States
Samy Babai
Citations per year, relative to Samy Babai Samy Babai (= 1×) peers Saba Sile

Countries citing papers authored by Samy Babai

Since Specialization
Citations

This map shows the geographic impact of Samy Babai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samy Babai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samy Babai more than expected).

Fields of papers citing papers by Samy Babai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samy Babai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samy Babai. The network helps show where Samy Babai may publish in the future.

Co-authorship network of co-authors of Samy Babai

This figure shows the co-authorship network connecting the top 25 collaborators of Samy Babai. A scholar is included among the top collaborators of Samy Babai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samy Babai. Samy Babai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Abbasi, Fariborz, et al.. (2025). Comparison study between different treatment planning techniques for medulloblastoma in terms of dosimetry, radiobiology, and secondary cancer risk. Journal of Cancer Research and Therapeutics. 21(1). 165–179.
2.
Châtellier, Gilles, et al.. (2024). Prevalence and risks of intravenous chemotherapy-induced severe neutropenia in solid cancers: a multicenter retrospective cohort study on real-life data. Supportive Care in Cancer. 32(10). 657–657. 1 indexed citations
3.
Lambotte, Olivier, et al.. (2024). Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports. European Journal of Hospital Pharmacy. 32(3). 286–288.
4.
Laroche, Marie‐Laure, et al.. (2020). Incretin-based drugs and intestinal obstruction: A pharmacovigilance study. Therapies. 75(6). 641–647. 25 indexed citations
5.
Petitpain, Nadine, Franck Rouby, Marion Sassier, et al.. (2019). Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database. Scientific Reports. 9(1). 19419–19419. 52 indexed citations
6.
Babai, Samy, et al.. (2019). Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study. Drug Safety. 43(2). 111–117. 19 indexed citations
7.
Babai, Samy, Laurent Auclert, & Hervé Le-Louët. (2018). Safety data and withdrawal of hepatotoxic drugs. Therapies. 76(6). 715–723. 74 indexed citations
8.
Petitpain, Nadine, Franck Rouby, Marion Sassier, et al.. (2018). Thyroiditis and immune check point inhibitors: the post‐marketing experience using the French National Pharmacovigilance database. Fundamental and Clinical Pharmacology. 33(2). 241–249. 15 indexed citations
9.
Neuzillet, Cindy, Samy Babai, Emmanuelle Kempf, et al.. (2016). Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion. Medicine. 95(26). e4006–e4006. 2 indexed citations
10.
Béné, Johana, Guillaume Moulis, Marine Auffret, et al.. (2016). Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database. British Journal of Dermatology. 175(2). 296–301. 129 indexed citations
11.
Béné, Johana, Pierrick Coupé, Marine Auffret, et al.. (2014). Bullous pemphigoid induced by vildagliptin: a report of three cases. Fundamental and Clinical Pharmacology. 29(1). 112–114. 49 indexed citations
12.
13.
Faillie, Jean‐Luc, Samy Babai, Sabrina Crépin, et al.. (2013). Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database. Acta Diabetologica. 51(3). 491–7. 61 indexed citations
14.
Babai, Samy, et al.. (2010). Comparison of Adverse Drug Reactions with Donepezil versus Memantine: Analysis of the French Pharmacovigilance Database. Therapies. 65(3). 255–259. 13 indexed citations
15.
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saba Sile Breakdown of academic impact, for papers by Marius MacKenzie Breakdown of academic impact, for papers by Stefano Di Giulio Breakdown of academic impact, for papers by Seiichi Hayato Breakdown of academic impact, for papers by Ziba Rahimi Breakdown of academic impact, for papers by Kevin Rockich Breakdown of academic impact, for papers by Elisabeth del Río Breakdown of academic impact, for papers by Tao Jin Breakdown of academic impact, for papers by Beatriz Sánchez-Vega Breakdown of academic impact, for papers by Kiichiro Jinde
Rankless by CCL
2026